e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunotherapy using IL-2 potentially reverse disorders of Th1 /Th17 response in patients with MDR-TB
Q. Tan, R. Min, H. Wang, W. P. Xie, Z. H. Xu, M. Huang, W. G. Xu (Nanjing, China)
Source:
Annual Congress 2013 –Drug-resistant tuberculosis
Session:
Drug-resistant tuberculosis
Session type:
Thematic Poster Session
Number:
2816
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Q. Tan, R. Min, H. Wang, W. P. Xie, Z. H. Xu, M. Huang, W. G. Xu (Nanjing, China). Immunotherapy using IL-2 potentially reverse disorders of Th1 /Th17 response in patients with MDR-TB. Eur Respir J 2013; 42: Suppl. 57, 2816
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Screening for latent TB using antigen-specific IP-10 response and the effect of prednisolon
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012
Altered imbalance between Th17 and regulatory T-cells and impaired Th1 response in the recovery of multidrug-resistant tuberculosis
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Utility of antigen-specific IFN-gamma assays for monitoring of disease activity and efficacy of anti-TB treatment in HIV-/TB+ and HIV+/TB+ patients in Bulgaria
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006
The IL-2-dependent Th1 response to bacterial infections is suppressed in COPD
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012
Distinct profiles of Th1 and Th2 cytokines in patients with IPF, CTD-ILD, and IPAF
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
COPD is associated with a Th1 cytokine profile
Source: Eur Respir J 2005; 26: Suppl. 49, 106s
Year: 2005
Lung and blood Th1 and Th17 responses against mycobacterial antigens in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Different Th1 and Th2 citokine profile in serum and tumor microciculation of SCLC and NSCLC patients
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Does diabetes mellitus affect T-cell interferon-gamma responses in TB patients?
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
Impaired Mtb-specific alveolar T-cell responses in HIV+ persons with latent TB infection
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
ESAT-6/CFP-10 and PPD-stimulated cytokine production in patients with MTB infection
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007
Allergen-specific immunotherapy results in increased IL-10 production of mononuclear cells and T-cell anergy
Source: Eur Respir J 2003; 22: Suppl. 45, 110s
Year: 2003
Late Breaking Abstract: A role for IL-25 as ‘initiator‘ in Th2 driven inflammation is restricted to IL-5 high Th2 patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Antigen-specific multifunctional T-cells in sarcoidosis patients with Löfgren’s syndrome
Source: Eur Respir J 2012; 40: 110-121
Year: 2012
Regulatory T-cells and high levels of FOXP3 mRNA lead to decreased immune responses during HIV-TB co-infection
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from successfully treated disease
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Expression of Th1, Th2 and Th17 cytokines in CD4
+
T cells in peripheral blood of asthma patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept